Case report of IgG4-related appendiceal disease: A challenging disease. Issue 25 (19th June 2020)

• Record Type: Journal Article
• Authors: Dias, Adriano Basso; Horvat, Natally; Begnami, Maria Dirlei; Abe, Emerson Shigueaki; Viana, Publio Cesar Cavalcante; Machado, Marcel Cerqueira Cesar
• Other Names: Saranathan. Maya section editor.
• Is Part Of: Medicine. Volume 99:Issue 25(2020)
• Publication Date: 2020-06-19
• Subjects: appendicitis -- appendix -- case report -- immunoglobulin G4-related disease -- multidetector computed tomography; Medicine -- Periodicals; Medicine -- Periodicals; Médecine -- Périodiques; Geneeskunde; Medicine; Periodicals; Periodicals; 610.5
• DOI: 10.1097/MD.0000000000020588
• Languages: English
• ISSNs: 0025-7974

Abstract

Abstract: Rationale: Immunoglobulin G4 (IgG4)-related disease is an increasingly recognized immune-mediated entity that can affect virtually every organ system. Depending on the location of the disease, it can present a wide range of clinical manifestations and even mimic malignancies. Appendiceal involvement in patients with IgG4-related disease is particularly rare and very few cases are reported in the literature. Patient concerns: We report a case of IgG4-related appendiceal disease in a 42-year-old woman who presents with a subacute onset of right lower quadrant abdominal pain. Diagnosis: Abdominal computed tomography showed a markedly enlarged appendix, raising the concern of malignancy. The diagnosis of IgG4 appendiceal disease was confirmed by postoperative histopathologic and immunohistochemical examination. Interventions: The patient underwent right hemicolectomy. Outcomes: After the surgery, the patient had an uneventful recovery and reported a resolution of her symptoms. The serum IgG4 was revaluated 5 days after surgery and returned to its normal values. At the 3-year follow up, the patient had no recurrence of symptoms and her imaging exams remain unremarkable. Lessons: This study reports the fifth case of IgG4-related appendiceal disease. Increasing awareness of this condition may influence the management of these patients, once patients with IgG4-related disease should be monitored after treatment, due to the risk of recurrence or involvement of other organs.